Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Lilly discovers arylpiperazines acting as both 5-HT reuptake inhibitors, 5-HT1D antagonists

May 31, 1999

Potent and selective 5-HT1A receptor agonists developed at Pierre Fabre

May 31, 1999

Menarini's chiral NSAID launched in U.K.

May 31, 1999

Genistein may offer protection against ALS and stroke

May 31, 1999

Noven's transdermal patch for ADHD Rx shows promise in initial clinical study

May 31, 1999

New gerontogene discovered by GenoPlex; further study funded by NIH

May 28, 1999

Dopamine D4 receptor ligands useful for schizophrenia claimed by Neurogen and Schering-Plough

May 28, 1999

News from APA: Adderall has significant advantages over Ritalin in treatment of ADHD

May 27, 1999

Dopaminergic and serotonergic ligands in development at Sanofi-Synthelabo

May 27, 1999

Antalarmin suppresses stress-related behavior in nonhuman primate model

May 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...